A review on comparative study of PPI and PAMAM dendrimers

Journal of Nanoparticle Research

Volumn 18, Issue 6, 2016, Pages

  Kaur, Daljeet ^a   Jain, Keerti ^a,b   Mehra, Neelesh Kumar ^a,c   Kesharwani, Prashant ^d   Jain, Narendra K ^a,e  

^a ISF COLLEGE OF PHARMACY   (India)

^b National Institute of Pharmaceutical Education and Research (NIPER)   (India)

^c TEXAS A AND M UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Biomedical applications; Dendrimers; Drug delivery; PAMAM; PPI; Properties; Synthesis; Toxicity

Indexed keywords

DENDRIMERS; DRUG DELIVERY; MEDICAL APPLICATIONS; SYNTHESIS (CHEMICAL); TOXICITY;

BIOMEDICAL APPLICATIONS; DRUG DELIVERY APPLICATIONS; FUNCTIONAL END GROUPS; PAMAM; POLY(PROPYLENE IMINE); POLYAMIDOAMINE DENDRIMERS; PROPERTIES; SURFACE FUNCTIONAL GROUPS;

FUNCTIONAL POLYMERS;

DENDRIMER; POLY(PROPYLENEIMINE) DENDRIMER; POLYAMIDOAMINE DENDRIMER; UNCLASSIFIED DRUG;

CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; EXTRAVASATION; FULL GENERATION SYNTHESIS; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HALF GENERATION SYNTHESIS; MEDICAL DEVICE; MICROVASCULAREXTRAVASATION; NANOTOXICOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SURFACE CHARGE; SURFACE PROPERTY; SYNTHESIS; TOXICITY TESTING;

EID: 84976277178     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-016-3423-0     Document Type: Review

References (88)

1. Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Hanifepour Y, Nejatikoshki K, Pashaei-Asl R (2014) Dendrimers: synthesis, applications and properties. Nanoscale Res Lett 9:247
2. Akhter S, Ahmed I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, Ahmad FJ, Storm G, Kok RJ (2013) Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets 13:362–378
3. Alamry KA, Georgiev NI, EI-Daly SA, Taib LA, Bojinov VB (2015) A highly selective ratiometric fluorescent pH probe based on a PAMAM wavelength-shifting bichromophoric system. Spectrochim Acta A 135:792–800
4. Aldosari OF (2011) Synthesis of some novel chiral dendrimers 1,1-binaphthyl derivatives. The University of Manchester, Manchester
5. Avti Pk, Kakkar A (2013) Dendrimers as anti-inflammatory agent. Braz J Pharm Sci 49:57–65
6. Azar NTP, Mutlu P, Khodadust R, Gunduz U (2013) Poly(amidoamine) (PAMAM) nanoparticles: synthesis and biomedical applications. J Biol Chem 41(3):289–299
7. Bagre AP, Jain K, Jain NK (2013) Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int J Pharm 456:31–40
8. Brabander-van den Berg EMM, Meijer EW (1993) Poly(propylene imine) dendrimers: large scale synthesis by heterogeneously catalyzed hydrogenation. Angew Chem Int Ed Engl 32:1308–1311
9. Buhleier E, Wehner W, Vogtle F (1978) Synthesis of molecular cavity topologies. Synthesis 2:155–158
10. Boas U, Christensen JB, Heegaard PMH (2006) Dendrimers in medicine and biotechnology. New molecular tools. Royal Society of Chemistry. doi:10.1039/9781847552679
11. Cheng Y, Qu H, Ma M, Xu Z, Xu P, Fang Y, Xu T (2007) Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolones antimicrobials: as in vitro study. Eur J Med Chem 42:1032–1038
12. Doshi M (2011) Dendrimers and its application. Int J Pharm Sci Rev Res 7:104–111
13. Drbohlavova J, Chomoucka J, Ryvolova M, Eckschlager T, Hubalek J, Kizek R (2013) Nanocarriers for anticancer drug—new trends in nanomedicine. Curr Drug Metab 14:547–564
14. Dufes C, Uchegbu IF, Schatzlein AG (2005) Dendrimers in gene delivery. Adv Drug Deliv Rev 57:2177–2202
15. Duncan R, Izzo L (2005) Dendrimers biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215–2237
16. Duran-Lara E, Guzman L, John A, Fuentes E, Alarcon M, Palomo L, Santos LS (2013) PAMAM dendrimer derivatives as a potential drug for antithrombotic therapy. Eur J Med Chem 69:601–608
17. Dutta T, Garg M, Dubey V, Mishra D, Singh K, Pandita D (2008) Toxicological investigation of surface engineered fifth generation poly(propyleneimine) dendrimers. Nanotechnology 2(2):62–70
18. Esfand R, Tomalia DA (2001) Poly(amidoamine) (PAMAM) dendrimers: from biomimicry delivery and biomedical applications. Drug Discov Today 6:427–436
19. Gajjar D, Patel R, Patel H, Patel PM (2014) Triazine based dendrimer as solubility ketoprofen: effect of concentration pH and generation. Int J Pharm Pharm Sci 6(4). ISSN 0975-1491
20. Gauniya A, Mazumder R, Pathak K (2014) Nanocrystals: a challenge for improved drug delivery. Asian J Biochem Pharm Res 4(3):282–192
21. Gómez-Valadés AG, Molas M, Vidal-Alabró A, Bermúdez J, Bartrons R, Perales JC (2005) Copolymers of poly-l-lysine with serine and tryptophan form stable DNA vectors: implications for receptor-mediated gene transfer. J Control Release 102:277–291
22. Gupta U, Agashe HB, Jain NK (2007) Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes. J Pharm Pharm Sci 10:358–367
23. Gupta U, Dwivedi SKD, Bid HK, Konwar R, Jain N (2010) Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cell. Int J Pharm 393:186–197
24. Hari B, Kalaimagal K, Porkodi R, Gajula PK, Ajay J (2012) Dendrimer: globular nanostructured materials for drug delivery. Int J PharmTech Res 4:432–451
25. Hembade MJ, Kangane MR, Mansuk AG, Lukkad HR (2013) Dendrimers: as promising nanocarriers for drug delivery. Int J Pharm Arch 2(4):61–70
26. Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, Jiang C (2007) Efficient gene delivery targeted to the brain using a transferrin conjugated polyethylene glycol modified polyamidoamine dendrimer. FASEB J 21:1117–1125
27. Jain K, Jain N (2014) Surface engineered dendrimers as antiangiogenic agent and carrier for anticancer drug: dual attack on cancer. J Nanosci Nanotechnol 14:5075–5087
28. Jain K, Kesharwani P, Gupta U, Jain N (2010) Dendrimer toxicity: let’s meet the challenge. Int J Pharm 394:122–142
29. Jain K, Kesharwani P, Gupta U, Jain NK (2012) A review of glycosylated carriers for drug delivery. Biomaterials 33:4166–4186
30. Jain A, Jain K, Kesharwani P, Jain N (2013a) Low density lipoproteins mediated nanoplatforms for cancer targeting. J Nanopart Res 15:1–38
31. Jain A, Jain K, Mehra NK, Jain NK (2013b) Lipoproteins tethered dendrimeric nanoconstructs for effective targeting to cancer cells. J Nanopart Res 15:1–18
32. Jain K, Gupta U, Jain NK (2014a) Dendronized nanoconjugates of lysine and folate for treatment of cancer. Eur J Pharm Biopharm 87:500–509
33. Jain K, Mehra NK, Jain NK (2014b) Potential NAD emerging trends in nanopharmacology. Curr Opin Pharmacol 15:97–106
34. Jain K, Verma AK, Mishra P, Jain NK (2015a) Characterization and evaluation of Amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers. Nanomedicine. doi:10.1016/j.nano.2014.11.008
35. Jain K, Verma AK, Mishra P, Jain NK (2015b) Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of Amphotericin B: formulation development, in vitro and in vivo evaluation. Antimicrob Agents Chemother. doi:10.1128/AAC.04213-14
36. Jansen JFGA, Meijer EW, Debrabander Van-denberg EMM (1995) The dendritic box: shape-selective liberation of encapsulated guests. J Am Chem Soc 117:4417–4418
37. Jones CF, Campbell RA, Brooks AE, Assemi S, Tadjiki S, Thiagarajan G, Mulcock C, Weyrich AS, Brooks BD, Ghandehari H, Grainger DW (2012) Cationic PAMAM dendrimers aggressively initiate blood clot formation. ACS Nano 6(11):9900–9910
38. Kesharwani P, Iyer AK (2015) Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug Discov Today 20(5):536–547
39. Kesharwani P, Tekade RK, Gajnhiye V, Jain K, Jain NK (2011) Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine 7:295–304
40. Kesharwani P, Jain K, Jain NK (2014a) Dendrimer as nanocarrier for drug delivery. Polym Sci 39:268–307
41. Kesharwani P, Tekade RK, Jain NK (2014b) Formulation development and in vitro–in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector. Nanomedicine 9(15):1–18
42. Kesharwani P, Tekade RK, Jain NK (2014c) Generation dependent cancer targeting poly(propyleneimine) dendrimer. Biomaterials 35:5539–5548
43. Kesharwani P, Tekade RK, Jain NK (2015a) Dendrimer generational nomenclature: the need to harmonize. Drug Discov Today 20(5):497–499
44. Kesharwani P, Banerjee S, Gupta U, Mohd Amin MCI, Padhye S, Sarkar FH, Iyer AK (2015b) PAMAM dendrimers as promising nanocarriers for RNAi therapeutics. Mater Today 18:565–572
45. Kesharwani P, Xie L, Banerjee S, Mao G, Padhye S, Sarkar FH, Iyer AK (2015c) Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Colloids Surf B 136:413–423
46. Kitchens KM, EI-Sayed ME, Ghandehari H (2005) Transepithelial and endothelial transport of poly(amidoamine) dendrimers. Adv Drug Delivery Rev 57:2163–2176
47. Klajnert B, Bryszewska M (2000) Dendrimers: properties and application. Acta Biochim Pol 48:199–208
48. Klajnert B, Pikala S, Bryszewska M (2010) Haemolytic activity of polyamidoamine dendrimers and the protective role of human serum albumin. Proc R Soc A 466:1527–1534
49. Kumari A, Singla R, Guliani A, Yadav SK (2014) Nanoencapsulation for drug delivery. EXCLI J 13:265–286
50. Landge DA, Shyale S, Kadam SD, Shah DV, Katare YS, Pawar JB (2014) Dendrimer: innovative acceptable approach in novel drug delivery system. Pharmacophore 5:24–34
51. Lee JW, Kim B, Kim JH, Shin WS, Jin S (2005) Facile synthesis of Frechet type dendritic benzyl azides and dendrimer via cycloaddition reaction with tripodal core. Bull Korean Chem Soc 26:1790
52. Leng ZH, Zhuang QF, Li YC, He Z, Chen Z, Huang SP, Jia HY, Zhou JW, Liu Y, Du LB (2013) Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate. Carbohydr Polym 98:1173–1178
53. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW (2000) Dendrimers versatile vectors in gene delivery. J Control Release 65:133–148
54. Malik A, Chaudhary S, Garg G, Tomar A (2012) Dendrimers: a tool for drug delivery. Adv Biol Res 6:165–169
55. Marvaniya HM, Parikh PK, Vr Patel, Modi KN, Sen DJ (2010) Dendrimer versatile vectors in gene delivery. J Chem Pharm Res 2:97–108
56. Mehra NK, Jain K, Jain NK (2015) Pharmaceutical and biological applications of surface engineered carbon nanotubes. Drug Discov Today. doi:10.1016/j.drudis.2015.01.006
57. Menjoge AR, Kannan RM, Tomalia DA (2010) Dendrimer-based drug and imaging conjugate: design consideration for nanomedical applications. Drug Discov Today 15:171–185
58. Mishra I (2011) Dendrimer: a novel drug delivery system. JDDT 1(2):70–74
59. Mishra V, Kesharwani P (2016) Dendrimer technologies for brain tumor. Drug Discov Today. doi:10.1016/j.drudis.2016.02.006 (Epub ahead of print)
60. Mishra V, Gupta U, Jain N (2015) Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Die Pharm Int J Pharm Sci 65:891–895
61. Mullen DG, Desai A, van Dongen MA, Barash M, Baker JR Jr, Banaszak Holl MM (2012) Best practices for purification and characterization of PAMAM dendrimer. Macromolecules 45:5316–5320
62. Myers VS, Weir MG, Carino EV, Yancey DF, Pande S, Crooks RM (2001) Dendrimer-encapsulated nanoparticles: new synthetic and characterization method and catalytic applications. Chem Sci 2:1632–1646
63. Narayan PS, Pooja S, Khushboo A, Diwakar T, Ankit S, Singhai A (2010) A novel drug delivery system. Int J Pharm Life Sci 1(7):382–388
64. Newkome GR, Shreiner CD (2008) Poly(amidoamine), polypropyleneimine and related dendrimers and dendrons possessing different 1 → 2 branching motifs: an overview of the divergent procedure. Polymer 49:1–73
65. Newkome GR, Yao ZQ, Baker GR, Gupta VK (1985) Cascade molecules: a new approach to micelles. J Org Chem 2003–2004:50
66. Oliveira JM, Salgado AJ, Sousa N, Mano JF, Reis RL (2010) Dendrimers and derivatives as a potential therapeutics tool in regenerative medicine strategies—a review. Prog Polym Sci 35:1163–1194
67. Pakhare SS, Tambe RV, Jadhav MG, Tiwari SS (2000) Dendrimers: a smart polymer. IJRRAS 2(3):513–528
68. Patel H, Patel P (2013) Dendrimer application—a review. Int J Pharm Biol Sci 4:454–463
69. Patidar A, Thakur DS (2011) Dendrimers: potential carriers for drug delivery. J Pharm Sci Nanotechnol 2011:4
70. Peterson J (2001) Synthesis and CZE analysis of PAMAM dendrimers with an ethylenediamine core. Proc Est Acad Sci Chem 50(3):156–166
71. Pyreddy S, Kumar PD, Kumar PV (2014) Polyethylene glycolated PAMAM dendrimers-conjugates. Int J Pharm Investig 4:15
72. Sampathkumar SG, Yarema KJ (2007) Dendrimers in cancer treatment and diagnosis. Nanotechnol Life Sci 7:1–43
73. Shah N, Steptoe RJ, Parekh HS (2011) Low-generation asymmetric dendrimers exhibit toxicity and effectively complex DNA. J Pept Sci 17:470–478
74. Shan Y, Luo T, Sheng R, Cao A, Cao X, Shen M, Guo R, Tomas H, Shi X (2012) Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vector. Biomaterials 33:3025–3035
75. Shao N, Su Y, Hu J, Zhang J, Zhang H, Cheng Y (2011) Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropyleneimine dendrimer on drug loading, complex structure, release behaviour and cytotoxicity. Int J Nanomed 6:3361
76. Silva N Jr, Menacho F, Chorilli M (2012) Dendrimers as potential platform in a no technology-based drug delivery system. IOSR J Pharm 2:23–30
77. Singla H, Singla N (2014) Novel role of nanotechnology in medicine. Int J Biomed Res 5:482–486
78. Svenson S (2009) Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 71:445–464
79. Thatikonda S, Yellanki SK, Swamy Charan D, Arjun D, Balaji A (2013) Dendrimers—a new class of polymers. Int J Pharm Sci Res 4:2174–2183
80. Tomalia DA, Baker H, Dewald JR, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P (1985) A new class of polymers: starburst-dendritic macromolecules. Polym J 17:117–132
81. Tomalia DA, Naylor AM, Goddard WA III (1990) Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed 29:138–175
82. Tomalia DA, Christensen JB, Boas U (2012a) Dendrimers, dendrons and dendritic polymers: discovery, applications, the future. Cambridge University Press, Cambridge
83. Tomalia DA, Christensen JB, Boas U (2012b) Chapter 3. In: Dendrimers, dendrons and dendritic polymers: discovery, applications, the future. Cambridge University Press, Cambridge, p 113–161
84. Tripathy S, Das MK (2013) Dendrimers and their applications as novel drug delivery carriers. J Appl Pharm Sci 3:142–149
85. Volcke C, Pirotton S, Grandfils C, Humbert C, Thiry PA, Ydens I et al (2006) Influence of DNA condensation state on transfection efficiency in DNA/polymer complexes: an AFM and DLS comparative study. J Biotechnol 125:11–21
86. Winnicka K, Bielawski K, Rusak M, Bielawska A (2009) The effect of generation 2 and 3 poly(amidoamine) dendrimers on viability of human breast cancer cells. J Health Sci 55:169–177
87. Wu J, Huang W, He Z (2013) Dendrimers as carriers for siRNA delivery and gene silencing: a review. Sci World J. doi:10.1155/2013/630654
88. Ziemba B, Halets I, Shcharbin D, Appelhans D, Voit B, Pieszynski I, Bryszewska M, Klajnert B (2012) Influence of fourth generation poly(propyleneimine) dendrimers on blood cells. J Biomed Mater Res A 100:2870–2880